1-benzyl-4-[4-(5-[4-methoxy-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl]-1H-pyrazol-1-yl)phenyl]-1H-pyrazole | 885132-53-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-benzyl-4-[4-(5-[4-methoxy-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl]-1H-pyrazol-1-yl)phenyl]-1H-pyrazole
• 英文别名: 1-benzyl-4-[4-[5-[4-methoxy-3-[(3R)-oxolan-3-yl]oxyphenyl]pyrazol-1-yl]phenyl]pyrazole
• CAS: 885132-53-6
• 化学式: C₃₀H₂₈N₄O₃
• 分子量: 492.577
• InChiKey: FKBSUHDEZKOQBX-HHHXNRCGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  37
• 可旋转键数：
  8
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  63.3
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• Phosphodiesterase 4 inhibitors
  申请人：Dunn F. Robert

  公开号：US20070254913A1

  公开（公告）日：2007-11-01

  Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.

  选择性PDE4抑制是通过芳基和杂环基吡唑化合物实现的。与罗利普兰（rolipram）等化合物相比，这些化合物表现出更好的PDE4抑制作用，并且在抑制其他类PDE时表现出选择性。
• ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES
  申请人：Ingrassia Laurent

  公开号：US20100076005A1

  公开（公告）日：2010-03-25

  Isocarbostyril alkaloid derivatives having an anti-proliferative and anti-migratory activities are disclosed. In particular, compounds of formula (I) or (II), as well as stereoisomers, tautomers, racemates, prodrugs, metabolites thereof, pharmaceutically acceptable salt and/or solvate are encompassed which are useful in the treatment and prophylaxis of cancer. Methods of preparation are also disclosed.

  揭示了具有抗增殖和抗迁移活性的异喹啉生物碱衍生物。具体来说，公开了符合以下化学式(I)或(II)的化合物，以及其立体异构体、互变异构体、消旋体、前药、代谢物、药学上可接受的盐和/或溶剂，这些化合物在癌症的治疗和预防中很有用。还公开了制备方法。
• PHOSPHODIESTERASE 4 INHIBITORS
  申请人：HOPPER Allen

  公开号：US20080207660A1

  公开（公告）日：2008-08-28

  Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.

  选择性PDE4抑制是由芳基和杂环基吡唑化合物实现的。这些化合物与类似于罗利普兰的化合物相比，表现出更好的PDE4抑制作用，并且在抑制其他类别的PDE方面表现出选择性。
• PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS
  申请人：Memory Pharmaceuticals Corporation

  公开号：EP1799673A1

  公开（公告）日：2007-06-27
• US7432266B2
  申请人：——

  公开号：US7432266B2

  公开（公告）日：2008-10-07